A recent study showed that a decrease in CREB-mediated transcriptional activity attenuated bone cancer-evoked pain behaviors and reduced CREB-target gene expression of the N-methyl-D-aspartate receptor subunit 2B (NMDAR2B)46. This evidence concerns the gene GRIN2B and bone neoplasm.